Regis Technologies, a contract development and manufacturing organization (CDMO) for small molecule active pharmaceutical ingredients (API), has introduced a new solid state chemistry service.
 
The new service will provide salt, cocrystal, and polymorph screening and selection activities to provide suitable crystallization processes during all development phases for Regis’ Custom Pharma clients.
 
Solid state chemistry director Dr. Ronald L. Mueller has developed a dedicated lab with state-of-the-art equipment for a team of experienced, solid state chemists and is now accepting projects.